The development of a probe to measure the body’s immune function could lead to more accurate, individualized doses for cancer patients prescribed nanoparticle-based drugs, according to research conducted at the University of North Carolina. Nanodrugs are encapsulated in carriers measured … Read more
IPIT drops “institute” in favor of “center” to become CPIT Tim Wiltshire is the new director. Federico Innocenti is the associate director. CPIT pursues genetic research aimed at getting patients the best results from medicines. Tim Wiltshire, PhD, has been … Read more
A literature review published in The Oncologist by Dan Hertz, PharmD, PhD, a recent graduate of the UNC Eshelman School of Pharmacy, and his PhD adviser, Howard McLeod, PharmD, helped inform the Food and Drug Administration’s recommendations regarding a potential interaction … Read more
Bob Dupuis, PharmD, has been promoted to the rank of clinical professor in the Division of Pharmacotherapy and Experimental Therapeutics. Dupuis has been a member of the School’s faculty for nearly thirty years, directs the DPET Clinical Fellows Program, and … Read more
Akinyemi Oni-Orisan, PharmD, a doctoral student at the UNC Eshelman School of Pharmacy, received a two-year predoctoral fellowship from the American Heart Association. The fellowship will provide $25,000 a year to support Oni-Orisan’s research, which integrates both animal and human … Read more
Beta-blockers can keep heart failure patients alive and out of the hospital, but they only improve heart function in about 25 percent of patients. Unfortunately, characteristics such as age, gender or the cause of the heart failure do not explain … Read more
Internationally known AIDS and HIV researcher Angela Kashuba, PharmD, has been awarded the John A. and Deborah S. McNeill Jr. Distinguished Professorship at the UNC Eshelman School of Pharmacy. Kashuba studies the role of antiretroviral therapy in preventing the transmission … Read more
Kyunghee Yang, MS, a graduate student in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy, has been awarded the Amgen Predoctoral Fellowship for the 2012-2013 academic year. The fellowship is awarded annually to a … Read more
New cancer drugs must be thoroughly tested in preclinical models, often in mice, before they can be offered to cancer patients for the first time in phase I clinical trials. Key components of this process include pharmacokinetic and pharmacodynamic studies, … Read more
The Division of Pharmacotherapy and Experimental Therapeutics held its 2012 Fellows Day on Monday, June 18. The division’s fellows presented posters of their research, and second-year fellows were recognized for their accomplishments. The second-year fellows: Jessica Adams, who completed the … Read more
